Cleared Traditional

K180186 - Stat Profile Prime Plus Analyzer System

K180186 is an FDA 510(k) clearance for Stat Profile Prime Plus Analyzer System, manufactured by Nova Biomedical Corporation. The device is a Class 2 Chemistry device with product code GGZ cleared through the Traditional 510(k) pathway after a 212-day FDA review.

K180186 · Nova Biomedical Corporation · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2018
Decision
212d
Days
Class 2
Risk

K180186 is an FDA 510(k) clearance for the Stat Profile Prime Plus Analyzer System. Classified as Oxyhemoglobin (product code GGZ), Class II - Special Controls.

Submitted by Nova Biomedical Corporation (Walham, US). The FDA issued a Cleared decision on August 23, 2018 after a review of 212 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 864.7500 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Nova Biomedical Corporation devices

FDA 510(k) Submission Details - K180186

510(k) Number K180186 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 23, 2018
Decision Date August 23, 2018
Days to Decision 212 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
124d slower than avg
Panel avg: 88d · This submission: 212d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GGZ Device Classification - Class 2, Special Controls

Product Code GGZ Oxyhemoglobin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7500
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.